A pair of clinical data sets gives Novartis confidence in a new formulation of the company’s gene therapy Zolgensma for the ...

The theory behind leucovorin's use for autism postulates that some children have a blockage in the transport of folic acid into the brain that potentially contributes to neurological symptoms.

The process starts with visual, mental or physical sexual stimulation, triggering the brain to release dopamine, which ...

National MS Education and Awareness Month is celebrated each year in the US in March, after having been launched in 2003 by ...

Q4 2024 Earnings Call Transcript March 10, 2025 Lineage Cell Therapeutics, Inc. beats earnings expectations. Reported EPS is ...

A simple treatment algorithm to aid in the selection of appropriate DMTs reduces racial disparities in patients with ...

A new study reveals that pain and itch are processed by distinct neural circuits in the anterior cingulate cortex (ACC).

Tamajyn started taking the supplements in anticipation of her 40th birthday but says she didn't experience the expected benefits.

ALS, which is also known as Lou Gehrig's Disease, is a rare neurological disease that affects motor neurons — the nerve cells ...

Ivor Elrifi, CEO of Tiziana Life Sciences, expressed enthusiasm about this milestone, stating, "We are excited to initiate this important clinical study with the support of the ALS Association grant.